Vantage Financial Partners, LLC Abb Vie Inc. Transaction History
Vantage Financial Partners, LLC
- $357 Million
- Q4 2024
A detailed history of Vantage Financial Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Vantage Financial Partners, LLC holds 10,945 shares of ABBV stock, worth $1.9 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
10,945
Previous 9,840
11.23%
Holding current value
$1.9 Million
Previous $1.94 Million
0.05%
% of portfolio
0.54%
Previous 0.51%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
4,153Shares Held
1.29BCall Options Held
17MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$30.1 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.7 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$13.8 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$9 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$6.9 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $307B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...